Related Experiment Videos
Monosymptomatic hypochondriasis treated with tricyclic antidepressants.
The American Journal of Psychiatry
|December 1, 1984
Summary
Tricyclic antidepressants effectively treated two patients with disabling monosymptomatic hypochondriasis. This finding offers hope for managing this uncommon, debilitating illness.
Area of Science:
- Psychiatry
- Clinical Psychology
Background:
- Monosymptomatic hypochondriasis is an uncommon but debilitating psychiatric disorder.
- Limited treatment options exist for this condition.
Observation:
- Two patients with severe monosymptomatic hypochondriasis were treated.
- Both patients experienced significant symptom improvement.
Findings:
- Tricyclic antidepressants demonstrated efficacy in treating monosymptomatic hypochondriasis.
- This class of medication may be a viable therapeutic option.
Implications:
- The findings suggest a potential treatment avenue for patients suffering from monosymptomatic hypochondriasis.
- Further research is warranted to confirm these results in larger populations.